Charles River Laboratories International, Inc.
Save
13.64B
Market cap
28.78x
Current P/E
24.15x
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers.

Similar securities

Based on sector and market capitalization

Report issue